NO923397L - Avgivelsesanordning - Google Patents

Avgivelsesanordning

Info

Publication number
NO923397L
NO923397L NO92923397A NO923397A NO923397L NO 923397 L NO923397 L NO 923397L NO 92923397 A NO92923397 A NO 92923397A NO 923397 A NO923397 A NO 923397A NO 923397 L NO923397 L NO 923397L
Authority
NO
Norway
Prior art keywords
water
delivery device
capsule
releasing
soluble
Prior art date
Application number
NO92923397A
Other languages
English (en)
Other versions
NO923397D0 (no
Inventor
Howard Norman Ernest Stevens
Abdul Rashid
Massoud Makhshaee
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of NO923397L publication Critical patent/NO923397L/no
Publication of NO923397D0 publication Critical patent/NO923397D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Seal Device For Vehicle (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Refuse Collection And Transfer (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Massaging Devices (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En oral doseform nyttig for frigivelse av innholdene i en kapsel inn i det menneskelige legeme omfatter en vannimpermeabel kapsel med minst en åpning som er lukket med en vannopploselig eller vanndispergerbar plugg.
NO923397A 1990-03-02 1992-08-31 Avgivelsesanordning NO923397D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909004702A GB9004702D0 (en) 1990-03-02 1990-03-02 Dispensing device
PCT/GB1991/000317 WO1991012795A1 (en) 1990-03-02 1991-03-01 Dispensing device

Publications (2)

Publication Number Publication Date
NO923397L true NO923397L (no) 1992-08-31
NO923397D0 NO923397D0 (no) 1992-08-31

Family

ID=10671894

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923397A NO923397D0 (no) 1990-03-02 1992-08-31 Avgivelsesanordning

Country Status (20)

Country Link
EP (2) EP0517771B1 (no)
JP (1) JP3247693B2 (no)
KR (1) KR0177178B1 (no)
AT (1) ATE178790T1 (no)
AU (1) AU646244B2 (no)
CA (1) CA2077342C (no)
DE (1) DE69131129T2 (no)
DK (1) DK0517771T3 (no)
ES (1) ES2130136T3 (no)
FI (1) FI108400B (no)
GB (2) GB9004702D0 (no)
GR (1) GR3030007T3 (no)
HU (1) HU218675B (no)
IE (1) IE65251B1 (no)
NO (1) NO923397D0 (no)
NZ (1) NZ237290A (no)
PT (1) PT96921B (no)
RU (1) RU2094044C1 (no)
WO (1) WO1991012795A1 (no)
ZA (1) ZA911526B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE106015T1 (de) * 1990-09-28 1994-06-15 Pfizer Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
CA2156726C (en) * 1993-02-26 2000-10-17 Paula Denise Davis Bisacodyl dosage form
GB9320733D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled release device construction
GB9320732D0 (en) * 1993-10-08 1993-12-01 Scherer Corp R P Controlled delivery of liquid
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
US5516524A (en) * 1993-12-20 1996-05-14 The Procter & Gamble Company Laxative compositions containing bulk fiber
CA2193806A1 (en) * 1994-06-22 1995-12-28 Michael Cardamone Controlled release device and method
EP0940084A1 (en) * 1998-03-06 1999-09-08 Soremartec S.A. A composite food product and process for manufacturing same
GB2374582A (en) 2001-04-20 2002-10-23 Reckitt Benckiser Water soluble container containing a composition
GB2375516A (en) * 2001-05-17 2002-11-20 Reckitt Benckiser Water soluble injection moulded container
GB2375517A (en) * 2001-05-17 2002-11-20 Reckitt Benckiser A water-soluble injection moulded container
WO2010103367A1 (en) 2009-03-09 2010-09-16 Council Of Scientific & Industrial Research Pulsatile release composition of therapeutic agent
US8251837B2 (en) * 2010-08-11 2012-08-28 Nike, Inc. Floating golf ball
RU2553310C2 (ru) * 2013-05-07 2015-06-10 Общество с ограниченной ответственностью "ЭДВАНСД ТРЕЙДИНГ" Капсульная форма клофазимина
TW201613565A (en) * 2014-10-15 2016-04-16 Bio Peptide Enhancer Tech Co Ltd Controlled release sealing capsule in stomach, duodenum, jejunum, ileum and colon
UY38610A (es) 2019-03-14 2020-08-31 Univ Greifswald Forma de dosificación farmacéutica para aplicación a membranas mucosas y métodos para producir la misma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB436236A (en) * 1934-04-26 1935-10-08 Karl Wilhelm Schmidt Improvements in and relating to a therapeutic capsule
GB1022171A (en) * 1961-06-15 1966-03-09 Wellcome Found Prolonged release oral pharmaceutical tablets and their manufacture
FR2100858B1 (no) * 1970-07-03 1975-06-06 Daiichi Seiyaku Co
BE794951A (fr) * 1972-02-03 1973-05-29 Parke Davis & Co Conditionnement soluble dans l'eau
GB2094256B (en) * 1981-03-05 1984-08-22 Standard Telephones Cables Ltd Controlled delivery capsule
GB8319766D0 (en) * 1983-07-22 1983-08-24 Graham N B Controlled release device
US4898733A (en) 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
GB2189390B (en) * 1986-04-16 1989-12-28 Stc Plc Material dispenser, e.g. for use as rumen boluses
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
DE69001831T2 (de) * 1989-02-16 1993-09-16 British Tech Group Wirkstoffabgabevorrichtung.

Also Published As

Publication number Publication date
WO1991012795A1 (en) 1991-09-05
EP0878190A1 (en) 1998-11-18
DE69131129D1 (de) 1999-05-20
HUT62464A (en) 1993-05-28
EP0517771B1 (en) 1999-04-14
ZA911526B (en) 1992-11-25
AU646244B2 (en) 1994-02-17
IE910693A1 (en) 1991-09-11
CA2077342C (en) 2001-04-24
GR3030007T3 (en) 1999-07-30
GB2241485A (en) 1991-09-04
FI923924A0 (fi) 1992-09-01
FI108400B (fi) 2002-01-31
ATE178790T1 (de) 1999-04-15
AU7443891A (en) 1991-09-18
CA2077342A1 (en) 1991-09-03
PT96921A (pt) 1993-03-31
NZ237290A (en) 1994-11-25
GB2241485B (en) 1994-01-12
NO923397D0 (no) 1992-08-31
HU218675B (hu) 2000-10-28
IE65251B1 (en) 1995-10-18
HU9202810D0 (en) 1993-04-28
DE69131129T2 (de) 1999-10-14
JP3247693B2 (ja) 2002-01-21
DK0517771T3 (da) 1999-10-25
JPH05506845A (ja) 1993-10-07
KR0177178B1 (en) 1999-03-20
RU2094044C1 (ru) 1997-10-27
PT96921B (pt) 1999-07-30
FI923924L (fi) 1992-09-01
ES2130136T3 (es) 1999-07-01
GB9104321D0 (en) 1991-04-17
GB9004702D0 (en) 1990-04-25
EP0517771A1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
GR1002564B (el) Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως.
NO892153L (no) Gastrisk retensjonssystem for kontrollert medikamentavgivelse.
AU623036B2 (en) Double-coated granules
NO159166C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater.
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
FI924247A7 (fi) Annostusmuoto lääkkeen vapauttamiseksi suoleen
GB8507779D0 (en) Drug carrier
TR199701018T1 (xx) Oral 2-metil-tieno-benzodiazepin form�lasyonu.
ES2051881T3 (es) Procedimiento de preparacion de un formulacion farmaceutica de liberacion prolongada.
SE8701900D0 (sv) Pulsed drug delivery
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ES522197A0 (es) Una valvula medica implantable en miniatura.
PT89071A (pt) Dispositivo para o fecho e selagem de envelopes, envelope e envelope com dispositivo de fecho e selagem
SE9201930D0 (sv) Gastric antibacterial treatment
NO934143D0 (no) Anordning for frigj!ring av en substans inn i et v{skelegeme
KR940008674A (ko) 경구용 약제
DE59503283D1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
ES2062794T3 (es) Derivados de (alquiltio-3 propil)-3 benzotiazolina, su preparacion y los medicamentos que les contienen.
SE8400453L (sv) Lekemedelspreparat med antitumorverkan
ATE131729T1 (de) 3,5-diiod-l-thyronin zur tsh-suppression und behandlung von struma
ATE85218T1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
ATE129405T1 (de) Ionophore enthaltende abgabevorrichtung.
NO891045L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolin-2,5-dion-derivater.
IT1244360B (it) Preparato di zinco idrossido per la terapia nell'uomo dell'ulcera gastrica e duodenale
NO891678L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.